Axsome Therapeutics, Inc. (AXSM) Description, Stock price, News & Info.

#ThinkSabio Latest News

Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint

Leave a Reply

Your email address will not be published. Required fields are marked *

Light
Dark